View printer-friendly version
« Back
May 03, 1999 10:21 a.m.
Teva Pharmaceutical Industries Limited Condensed Consolidated Statements of Income (in Thousands, Except Earnings Per ADR)

  March 31 Dec. 31
  1999 1998 1998
  U.S. Dollars
  (unaudited) (audited)
Assets      
Current Assets      
Cash and cash equivalents 69,780 60,927 47,074
Short-term investments 2,100 4,643 2,148
Accounts receivable:      
Trade 263,033 226,361 274,592
Other 87,907 56,610 99,182
Inventories 350,187 300,801 353,249
Total current assets 773,007 649,342 776,245
investments and non-current receivables: 31,839 25,203 32,566
       
property, plant and equipment:      
Cost 755,654 672,050 754,638
Less Accumulated depreciation 309,848 257,460 299,656
  445,806 414,590 454,982
intangible assets, net 167,809 80,315 172,205
  1,418,461 1,169,450 1,435,998
liabilities and shareholders' equity      
current liabilities      
Short-term credit-mainly from banks 319,067 219,298 324,534
Accounts payable and accruals:      
Trade 93,542 109,957 123,743
Other 90,709 73,885 84,814
Proposed Dividend 5,126 5,235 4,554
Total current liabilities 508,444 408,375 537,645
long-term liabilities:      
Deferred income taxes 31,114 12,543 33,172
Accrued employee rights upon retirement, net of amount funded 3,878 4,477 3,895
Loans and other liabilities 201,302 113,070 201,699
Total long-term liabilities 236,294 130,090 238,766
Total Liabilities 744,738 538,465 776,411
minority interest 481 703 781
shareholders' equity 673,242 630,282 658,806
  1,418,461 1,169,450 1,435,998